About me
Dr. Yoko Aoi is a Coordination Director, Office of Review Management at the PMDA of Japan. After joining PMDA, Dr. Aoi has been involved in regulatory review/scientific advice for new drugs, including treatments for rheumatoid arthritis, asthma, and COPD (2011–2016); coordination of international activities including PMDA Asia Training Center (2016–2019); and regulatory review/scientific advice for oncology drugs (2019–2025). She leads the Orphan Drugs Working Group, which addresses regulatory challenges in orphan drug development, and served as Deputy Topic Leader of the ICH E17 Expert Working Group/Implementation Working Group (2014-2020). Dr. Aoi holds a PhD from Tokyo Medical and Dental University, now Institute of Science Tokyo.
